PhRMA fires 14 PR firms in review

Share this article:

The Pharmaceutical Research and Manufacturers of America has cut its ties with 14 of the firms handling its state and regional PR as part of a wide-ranging review of its contractors. PhRMA senior vice president, communications Ken Johnson said that while he will not rule out an eventual consolidation, for the moment, the group is just assessing its needs and vendor relationships. "All we're trying to do right now is to make certain that we're getting value out of our contractors," said Johnson. "Over the course of the review, it has become clear that a number of our contractors were being underutilized, and so we ended those relationships." Among the firms pitching for PhRMA business are Edelman, APCO Worldwide and Hill & Knowlton. Fleishman-Hillard, previously in the running, has dropped out due to a client conflict.

Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.